Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FG001 imaging in glioblastoma patients scheduled for neurosurgery
2020-003089-38Phase 2Completed
- Sponsor
- FluoGuide
- Start
- Jul 2020
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of FG001 in glioblastoma (GBM), sponsored by FluoGuide. Started Jul 2020; status: completed.
02
Drugs
FG001
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on 2020-003089-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003089-38.